Publication details
Farmakoterapie těžkého srdečního selhání: současnost a vize.
| Title in English | Pharmacotherapy of severe heart failure: present and future. |
|---|---|
| Authors | |
| Year of publication | 2010 |
| MU Faculty or unit | |
| Citation | |
| Description | Patient with severe heart failure continues in receiving beta blockers or ACE inhibitors. Further drug therapy is digoxin and diuretics. The most severe patients receive also positive inotropes, in present dobutamine or levosimendan are the most frequently used. The substances for possible future use are istaroxim, omecantiv mecarbil and gene therapy. |
| Related projects: |